| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0205 |
| Trial ID | NCT02146924 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19CAR-CD28-CD3zeta-EGFRt-expressing T cell |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia |
| Year | 2014 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 13447|NCI-2014-01060|120202|111660|109630|113660|13447/115692|118097|13447 |
| Vector information | |||||||
|
|||||||
| Cohort1: Tcm-enriched T cell | |||||||||||
|
|||||||||||
| Cohort2: Tn/nem-enriched T cell | |||||||||||
|
|||||||||||